Name That Brand: October 2012

Share this article:

Brand X adds a new wrinkle to its story

Can you name the brand? Each month we print part of a popular pharmaceutical product or advertisement, with clues to its identity. Readers are invited to name the brand for a chance to win a copy of Medicine Ave 2: The Story of Medical Advertising in America 1990-2008. E-mail your answer to NameThatBrand@haymarketmedia.com or fax 646-638-6150. The deadline is October 31, 2012. The winner will be picked randomly from the correct entries.

Which side are you on? This blockbuster product has a seemingly endless list of applications, but its sister act, which has a completely different chemical makeup but similar cosmetic goal features a similar marketing color scheme, and, at first blush, purpose. Fans include time travelers and some headache patients, as well as the bottom line to which it added a smooth $1.6 billion in sales last year. A possible surprise: the majority of those sales came from its hidden benefits.

AUGUST'S WINNER...
Congratulations to Gail F. Johnson, VP, Group Copy Supervisor at H4B Catapult who correctly guessed Plan B One-Step, the pill from Teva Women's Health to prevent unwanted pregnancies.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?